treatment guidelines and vaccination once morest COVID-19 After adjusting to a contagious disease that must be monitored
As it has been announced that “Covid 19” is a “contagious disease under surveillance The Communicable Disease Act, B.E. 2558”
Effective from October 1, 2022 onwards due to the improvement of the epidemic situation in the country. The trend in the number of severe cases and the mortality rate decreased. Including the coverage of vaccination once morest diseases.
in most people
Dr. Kittiphan Chalom, Assistant Doctor of Public Health, Chiang Mai Province, mentioned that the guidelines for ATK testing will focus on those who have suspected symptoms such as stuttering, cough, sore throat, and runny nose.
Proactive investigations are carried out only in cases of suspected outbreaks. Surveillance is still being carried out by reporting cases from all healthcare facilities. And if an outbreak is found, the disease will be investigated and controlled by the Communicable Disease Control Unit (CDCU) available in every district.
for guidelines for treating patients Department of Medical Services has been revised as of September 29, 2022.
from expert opinion including academic information both domestically and internationally if no symptoms Antiviral medication is not required. The doctor will consider antiviral medication according to the symptoms and risks. (1) In the case of mild symptoms.
or a normal lung x-ray no risk factors or major co-morbidities provide outpatient treatment may consider giving medication
Paniculata paniculata or Favipiravir At the discretion of the physician. Follow the DMH strictly for 5 days (2) if applicable.
risk factors or major co-morbidities There may be mild pneumonia. or no risk factors but mild to moderate pneumonia Your doctor will consider giving you Paxlovid or remdesivir or molnupiravir and (3) if pneumonia requires oxygen. or the oxygen concentration in the blood is less than 94%, inpatient treatment Your doctor will prescribe remdesivir. For children under 18 and pregnant women if no symptoms or mild symptoms
Antiviral medication is not required. But if there are risk factors Your doctor will consider favipiravir. or remdesivir or if there is pneumonia will give remdesivir
also change “Separating the infected people” is a guide to action to reduce the risk in
transmission of infection by strictly following the DMH for the first 5 days, by separating the bedroom and refraining from leaving the house from
Onset of symptoms, if going out of the house as necessary and to wear a mask at all times Including maintaining a distance of regarding 1 meter or more from others, following the first 5 days can go out in the community more. But still should avoid contact with the elderly. or patients with chronic diseases and following 10 days can engage in social activities and work normally
Dr. Kittiphan also mentioned Vaccination once morest COVID-19 The Ministry of Public Health continues to provide vaccination services for COVID-19. and can receive services in hospitals at all levels and if the patient is at home or in bed can inform the VHV or public health officials to vaccinate them at home free of charge For receiving the immunosuppressive LAAB for the low-immunity group. by the group of patients who meet the criteria
Getting treatment can consult a doctor for injections, such as kidney failure patients undergoing dialysis. organ transplant patients receiving immunosuppressant drugs Arthritis or autoimmune patients receiving immunosuppressants including other low-immunity patients Vaccination for children aged 6 months to 4 years is in the process of preparing for service. Three injections will be given at weeks 0, 4 and 12 and can be given along with other vaccines. If the child has a history of infection, keep the distance before 3 months. Make the transition of COVID-19 from a dangerous communicable disease to a communicable disease that must be monitored safely.”
